Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127427972 | 12742797 | 2 | F | 20160716 | 20160920 | 20160914 | 20160927 | EXP | FR-PFIZER INC-2016421610 | PFIZER | 18.00 | YR | F | Y | 0.00000 | 20160927 | OT | FR | FR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127427972 | 12742797 | 1 | PS | ZITHROMAX | AZITHROMYCIN DIHYDRATE | 1 | Oral | 1000 MG, SINGLE | D | 50711 | 1000 | MG | FILM-COATED TABLET | ||||||
127427972 | 12742797 | 2 | SS | CEFTRIAXONE SODIUM. | CEFTRIAXONE SODIUM | 1 | 500 MG, SINGLE | D | 0 | 500 | MG | ||||||||
127427972 | 12742797 | 3 | SS | TRUVADA | EMTRICITABINETENOFOVIR DISOPROXIL FUMARATE | 1 | Oral | 1 DF, 1X/DAY | Y | 0 | 1 | DF | QD | ||||||
127427972 | 12742797 | 4 | SS | KALETRA | LOPINAVIRRITONAVIR | 1 | Oral | 2 DF, 2X/DAY | Y | 0 | 2 | DF | FILM-COATED TABLET | BID | |||||
127427972 | 12742797 | 5 | SS | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | Oral | 2 MG, 2X/DAY (MORNING AND EVENING) | Y | U | 0 | 2 | MG | CAPSULE | BID | ||||
127427972 | 12742797 | 6 | SS | PROGRAF | TACROLIMUSTACROLIMUS ANHYDROUS | 1 | 2 MG, 2X/DAY (MORNING AND EVENING) | Y | U | 0 | 2 | MG | CAPSULE | BID | |||||
127427972 | 12742797 | 7 | C | ORAP | PIMOZIDE | 1 | 1 MG, 1X/DAY | 0 | 1 | MG | QD | ||||||||
127427972 | 12742797 | 8 | C | PRAVASTATIN. | PRAVASTATIN | 1 | 5 MG, DAILY | 0 | 5 | MG | |||||||||
127427972 | 12742797 | 9 | C | DESOGESTREL | DESOGESTREL | 1 | 1 DF, DAILY | 0 | 1 | DF | TABLET | ||||||||
127427972 | 12742797 | 10 | C | ELLAONE | ULIPRISTAL ACETATE | 1 | UNK, SINGLE | 0 | |||||||||||
127427972 | 12742797 | 11 | C | XANAX | ALPRAZOLAM | 1 | 0.25 MG, AS NEEDED | 0 | .25 | MG | |||||||||
127427972 | 12742797 | 12 | C | VENTOLINE | ALBUTEROL | 1 | UNK, AS NEEDED | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127427972 | 12742797 | 1 | Prophylaxis urinary tract infection |
127427972 | 12742797 | 3 | Prophylaxis against HIV infection |
127427972 | 12742797 | 4 | Prophylaxis against HIV infection |
127427972 | 12742797 | 5 | Heart transplant |
127427972 | 12742797 | 11 | Anxiety |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127427972 | 12742797 | OT |
127427972 | 12742797 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127427972 | 12742797 | Electrocardiogram QT prolonged |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127427972 | 12742797 | 1 | 20160716 | 20160716 | 0 | |
127427972 | 12742797 | 2 | 20160716 | 20160716 | 0 | |
127427972 | 12742797 | 3 | 20160716 | 20160720 | 0 | |
127427972 | 12742797 | 4 | 20160716 | 20160720 | 0 | |
127427972 | 12742797 | 5 | 20160718 | 0 | ||
127427972 | 12742797 | 6 | 20160723 | 0 | ||
127427972 | 12742797 | 10 | 20160716 | 20160716 | 0 |